BioSpace News Archive

BioMidwest

Omron® Healthcare officially launches HeartGuide™, the first wearable blood pressure monitor, with new digital health service, HeartAdvisor™

Highly-anticipated medical device in the compact form of a wrist watch now available for retail sale in the U.S. at OmronHealthcare.com, pairs with new insights-driven mobile application

January 8, 2019
·
4 min read
Job Trends

Systems Oncology to Present at eChinaHealth Event During the 37th Annual J.P. Morgan Healthcare Conference

Systems Oncology today announced that Dr. Spyro Mousses, Chief Executive Officer, will present their rapidly growing pipeline of innovative oncology programs discovered with their ExpansiveAI platform, during the 37th annual J.P. Morgan Healthcare Conference in San Francisco, CA.

January 8, 2019
·
2 min read
Pharm Country

Thubrikar Announces First-in-Human Implant with the Optimum TAVI System

Thubrikar Aortic Valve, Inc. today announced the first human implant of the Optimum TAV using their transcatheter aortic valve implantation (TAVI) system.

January 8, 2019
·
3 min read
Policy

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS

Pomerantz LLP is investigating claims on behalf of investors of Alkermes plc

January 8, 2019
·
2 min read
Drug Development

Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Targeting Multiple Myeloma (MM)

Cellular Biomedicine Group Inc. today announces the initiation of patient recruitment to support the study of anti-BCMA CAR-T therapy targeting relapsed and refractory Multiple Myeloma in China.

January 8, 2019
·
5 min read
Deals

Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company

Transaction Expected to Create NASDAQ-listed Biopharmaceutical Company Focused on Advancing Immunic‘s Compelling Pipeline of Clinical-Stage and Late Preclinical Assets

January 8, 2019
·
15 min read
Drug Development

Karolinska Development’s portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin

Karolinska Development’s portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD).

January 8, 2019
·
2 min read
Business

Retrophin Provides Corporate Update and 2019 Outlook

Top-line readout of pivotal FORT Study in PKAN expected 3Q19

January 8, 2019
·
7 min read
Biotech Bay

Apollomics, Inc. (previously CBT Pharmaceuticals, Inc.) Raises $100 Million in Series B Financing

Financing will accelerate development of the Company’s cancer immunotherapy and targeted therapy programs

January 8, 2019
·
3 min read
Drug Development

STERNA BIOLOGICALS PREPARES FOR PHASE IIb CLINICAL PROGRAM WITH GATA-3 ANTAGONIST DRUG CANDIDATES SB010 IN ASTHMA AND SB012 IN ULCERATIVE COLITIS

Key preparatory steps to conduct phase IIb trials initiated, including CMC and regulatory activities in the EU and US

January 8, 2019
·
5 min read